State of New Jersey Common Pension Fund D
PensionPosition in PTGX — Protagonist Therapeutics, Inc
CIK 1483066
TRENTON, NJ
Position in PTGX
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$2,023,305
+$221,809 QoQ
Shares Held
16,506
-3.4% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#141
of 341 holders
Holding Since
Sep 2021
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026State of New Jersey Common Pension Fund D holds $243,793,580 across 143 Biotechnology names. PTGX ranks #26 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
82,245 | $40,853,558 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
33,596 | $20,948,449 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
42,883 | $12,909,069 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
52,307 | $9,796,054 | |
| 5 | MRNA |
Moderna, Inc.
|
108,545 | $7,601,406 | |
| 6 | RPRX |
Royalty Pharma plc
|
132,910 | $7,452,263 | |
| 7 | INSM |
INSMED Inc
|
68,049 | $7,255,384 | |
| 8 | INCY |
Incyte Corp
|
54,697 | $6,200,451 |
All Filings in PTGX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,023,305 | 16,506 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $1,801,496 | 17,092 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $1,483,644 | 16,987 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $2,521,417 | 37,956 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $2,267,451 | 41,025 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $2,598,672 | 53,736 | Shares | Sole | 2025-05-13 | |
| 2021-09-30 | $967,317 | 54,589 | Shares | Sole | 2021-10-27 | |
| No filing history on record for this holder in this stock. | ||||||